Albany Molecular Res (AMRI) 16.20 $AMRI Global Drug

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Albany Molecular Res (AMRI) 16.20 $AMRI

Global Drug Discovery Market Report 2016-2022 - Analysis, Technologies & Forecasts - Key Vendors: Infosys, Charles River Labs, Albany Molecular Research - Research and Markets
BusinessWire - Tue Sep 20, 6:49AM CDT
Research and Markets has announced the addition of the "Global Drug Discovery Market Analysis 2016 - Forecast to 2022" report to their offering.
AMRI: 16.20 (+0.03)

Lifshitz & Miller Law Firm Announces Investigation of Accuride Corporation, Albany Molecular Research Inc., Emergent BioSolutions, Inc., Flowers Foods, Inc., Orbital ATK, Inc., Quorum Health Corp., Stericycle, Inc., and SunPower Corporation
PR Newswire - Wed Sep 07, 3:06PM CDT
Accuride Corporation (ACW)
EBS: 28.36 (-0.38), ACW: 2.57 (+0.01), SRCL: 79.54 (+0.28), SPWR: 8.52 (+0.27), QHC: 6.28 (+0.03), OA: 74.44 (-0.33), AMRI: 16.20 (+0.03), FLO: 15.54 (-0.13)

AMRI CEO to Present at Morgan Stanley Global Healthcare Conference
PR Newswire - Tue Aug 30, 7:00AM CDT
Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 at 3:30 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web site at http://ir.amriglobal.com/events.cfm?CalendarID=2.
AMRI: 16.20 (+0.03), MS: 31.91 (-0.33)

AMRI CEO to Present at Baird 2016 Global Healthcare Conference
PR Newswire - Wed Aug 24, 7:00AM CDT
Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the Baird 2016 Global Healthcare Conference on Wednesday, September 7, 2016 at 1:25 p.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Relations web site at http://ir.amriglobal.com/events.cfm?CalendarID=2.
AMRI: 16.20 (+0.03)

AMRI Licenses CRISPR-Cas9 Gene Editing Technology
PR Newswire - Tue Aug 23, 3:05PM CDT
AMRI (NASDAQ: AMRI) today announced that it entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cas9 gene editing technology and has completed several projects for its customers. The company will continue to use the technology to enhance its drug discovery service offerings and internal research and development. Financial terms were not disclosed.
AMRI: 16.20 (+0.03)

Update in Lawsuit for Investors in Albany Molecular Research, Inc. shares announced by Shareholders Foundation
GlobeNewswire - Tue Aug 23, 9:05AM CDT
The Shareholders Foundation, Inc. announces that a lawsuit is pending in New York on behalf of certain purchasers of shares of Albany Molecular Research, Inc. (NASDAQ:AMRI) over alleged Securities Laws Violations by Albany Molecular Research.
AMRI: 16.20 (+0.03)

Ryan & Maniskas, LLP Announces Investigation of Albany Molecular Research Inc.
PR Newswire - Wed Aug 10, 5:00PM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Albany Molecular Research, Inc. ("Albany Molecular" or the "Company" (NASDAQ: AMRI).
AMRI: 16.20 (+0.03)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Albany Molecular Research, Inc. (AMRI)
PR Newswire - Tue Aug 09, 9:15AM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Albany Molecular Research, Inc. ("Amri" or the "Company" (NASDAQ: AMRI). Such investors are advised to contact Peretz Bronstein or his investor relations analyst, Yael Hurwitz at info@bgandg.com or 212-697-6484.
AMRI: 16.20 (+0.03)

Robbins Arroyo LLP Is Investigating the Officers and Directors of Albany Molecular Research, Inc. (AMRI) on Behalf of Shareholders
BusinessWire - Mon Aug 08, 12:03PM CDT
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Albany Molecular Research, Inc. (NASDAQGS: AMRI) breached their fiduciary duties to the company and its shareholders by failing to implement adequate internal controls over the company's management and disclosure procedures. Albany Molecular Research, a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia.
AMRI: 16.20 (+0.03)

AMRI Announces Second Quarter 2016 Results
PR Newswire - Thu Aug 04, 6:30AM CDT
AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2016 and provided an update to its outlook for 2016.
AMRI: 16.20 (+0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 5

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
Goddess Maintenance Co. Eyes BeautyMatter Award

Updated Category News Views 5

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 7

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 5

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
Solar Fencing Revolutionizes North Texas Homes

Updated Category News Views 5

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 5

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading

Top 5 Most Recently Viewed Articles

Tara Heaton's Life Minutes: Transforming Heartache into Joy

Updated Category News Views 216

The Inspiring Journey of Tara Heaton in Life Minutes Life Minutes is a profound memoir by Tara Heaton, a remarkable woman who illustrates the resilience of the human spirit. In this captivating narrative, Tara shares her journey to find joy amidst the pain of adversity. This book is a must-read for those who have ever faced loss or tragedy and are seeking hope and...

Continue Reading
Myricx Bio Welcomes Dr. Paolo Paoletti as New Board Member

Updated Category News Views 80

Myricx Bio Expands Board with Notable Appointment Myricx Bio, a cutting-edge biotech firm specializing in innovative cancer therapies, has announced the appointment of Dr. Paolo Paoletti, MD, to its Board of Directors as an Independent Non-Executive Director. This strategic addition is part of Myricx's ongoing efforts to enhance its leadership team and further develop its...

Continue Reading
Investigation Launched into Viatris Inc. by Law Firm Focused on Accountability

Updated Category News Views 106

Investigation into Viatris Inc. Pomerantz LLP is currently delving into potential claims regarding the performance and practices of Viatris Inc. This investigation focuses on allegations of possible securities fraud and other illegal business actions that may have affected investors. Recent Financial Results and Guidance The investigation follows Viatris’s recent...

Continue Reading
BlockchainCloudMining Leads in Sustainable Crypto Solutions

Updated Category News Views 196

Embracing a Sustainable Future in Crypto Mining As we step into a new era with evolving environmental awareness, companies like BlockchainCloudMining are shining examples of how the crypto mining industry can take bold steps towards sustainability. The conversation surrounding climate change and ecological responsibility is gaining traction, and on a recent World...

Continue Reading
Bitcoin Climbs to $66K as Ethereum, XRP, Dogecoin Stumble

Updated Category News Views 163

Market Rollercoaster: Bitcoin's Ascent Here’s the scoop—Bitcoin just bounced back over $65,000. After a chaos-fueled dip triggered by some beastly liquidations that eclipsed $500 million early Monday, traders have got their hands busy trying to make sense of this mercurial market. Gotta say, the way Bitcoin moves these days—like a cat on a hot tin roof! Anyway, with...

Continue Reading